Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-07

Clinical Trial Update: The Permacol Dutch Cohort Study

View source ↗

Summary

The Permacol Dutch Cohort study, sponsored by Erasmus Medical Center, has completed its evaluation of a biologic implant for abdominal wall hernia repair.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Permacol

Snippet

Sponsor: Erasmus Medical Center | Conditions: Hernia of Abdominal Wall, Biologic Implant | Status: COMPLETED